Search

everythinglearnresearchcommunity

for

Search:↓

The LustrivaTM BH-002 supplement and hair serum improved women's hair, skin, and nail health and appearance.

The new 5% minoxidil formulation without propylene glycol effectively promotes hair growth with fewer side effects and better user satisfaction.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Neem and Zanjabeel are as effective as standard drugs for treating hirsutism in PCOD patients.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

Unconventional home remedies can sometimes show surprising results.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Acne treatment, including isotretinoin, improves quality of life and does not worsen depression.

Oral zinc sulphate is an effective and safe treatment for thallium poisoning.

Two cycles of ABVD chemotherapy followed by 20 Gy radiotherapy is the new standard for early-stage Hodgkin lymphoma due to lower toxicity and similar effectiveness.

Topical minoxidil, intralesional steroids, and cryotherapy significantly improve alopecia areata.

The conclusion suggests that the zinc lozenge study is valid despite imperfect blinding, as many participants could not correctly identify their lozenge type.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Combining microneedling with either vitamin D3 or bimatoprost improves hair regrowth more than microneedling alone.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.

Combining minoxidil and spironolactone is more effective for female hair loss, but minoxidil alone is sufficient after 6 months.

Mesotherapy is more effective and preferred for female hair loss than topical minoxidil.

Minoxidil shampoo showed slight hair growth but needs longer testing for clear results.

Hair tonic helps stop hair loss in most users.

Placebo effects vary in hair loss trials, with split-scalp trials showing higher hair density after 6 months compared to whole-head trials.